Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
|
|
18.
|
|
|
19.
|
|
|
20.
|
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry. [electronic resource] by
- Gibson, P G
- Reddel, H
- McDonald, V M
- Marks, G
- Jenkins, C
- Gillman, A
- Upham, J
- Sutherland, M
- Rimmer, J
- Thien, F
- Katsoulotos, G P
- Cook, M
- Yang, I
- Katelaris, C
- Bowler, S
- Langton, D
- Robinson, P
- Wright, C
- Yozghatlian, V
- Burgess, S
- Sivakumaran, P
- Jaffe, A
- Bowden, J
- Wark, P A B
- Yan, K Y
- Kritikos, V
- Peters, M
- Hew, M
- Aminazad, A
- Bint, M
- Guo, M
Producer: 20170824
In:
Internal medicine journal vol. 46
Availability: No items available.
|